US testing 3 drugs to tamp down coronavirus
Posted by: [email protected]_84 | on October 16, 2020
WASHINGTON — U.S. government officials are launching a new study testing three drugs to tamp down an overactive response by the immune system that can cause severe illness or death in people with COVID-19.
The U.S. National Institutes of Health says the study will enroll 2,100 hospitalized adults with moderate to severe COVID-19 in the United States and Latin America. All will get the antiviral drug remdesivir plus one of the three “immune-modulating drugs” or a placebo.